LTA and Autoimmunity: Generating an inducible transgenic mouse model allowing LTα deletion at a specific time point, i.e., before or after the development of autoimmune signs, would be useful to define the potential of LTα as a new target to prevent or treat autoimmunity associated with defective T cell selection.